Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Vitucci

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Brain Research Bulletin|June 21, 2011
Genetically engineered mouse models of diffuse gliomasRalf S Schmid, Mark Vitucci, C Ryan Miller
Neuro-Oncology|September 24, 2014
Contemporary murine models in preclinical astrocytoma drug developmentRobert S McNeill, Mark Vitucci, Jing Wu, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 14, 2006
NKG2D ligands are expressed on stressed human airway epithelial cellsMichael T Borchers, Nathaniel L Harris, Scott C Wesselkamper, et al.
Experimental and Molecular Pathology|October 24, 2007
CD8+ T cells contribute to macrophage accumulation and airspace enlargement following repeated irritant exposureMichael T Borchers, Scott C Wesselkamper, Nathaniel L Harris, et al.
Journal of Visualized Experiments : Jove|August 23, 2014
Modeling astrocytoma pathogenesis in vitro and in vivo using cortical astrocytes or neural stem cells from conditional, genetically engineered miceRobert S McNeill, Ralf S Schmid, Ryan E Bash, et al.
Neuro-Oncology|July 2, 2013
Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesisMark Vitucci, Natalie O Karpinich, Ryan E Bash, et al.
Neuro-Oncology|January 31, 2016
Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomideRalf S Schmid, Jeremy M Simon, Mark Vitucci, et al.
Neuro-Oncology|April 12, 2017
Genomic profiles of low-grade murine gliomas evolve during progression to glioblastomaMark Vitucci, David M Irvin, Robert S McNeill, et al.
Nature Communications|March 15, 2018
Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodelingCarla Danussi, Promita Bose, Prasanna T Parthasarathy, et al.
Nature Communications|January 6, 2022
Author Correction: Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodelingCarla Danussi, Promita Bose, Prasanna T Parthasarathy, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Brain Research Bulletin|June 21, 2011
Genetically engineered mouse models of diffuse gliomasRalf S Schmid, Mark Vitucci, C Ryan Miller
Neuro-Oncology|September 24, 2014
Contemporary murine models in preclinical astrocytoma drug developmentRobert S McNeill, Mark Vitucci, Jing Wu, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 14, 2006
NKG2D ligands are expressed on stressed human airway epithelial cellsMichael T Borchers, Nathaniel L Harris, Scott C Wesselkamper, et al.
Experimental and Molecular Pathology|October 24, 2007
CD8+ T cells contribute to macrophage accumulation and airspace enlargement following repeated irritant exposureMichael T Borchers, Scott C Wesselkamper, Nathaniel L Harris, et al.
Journal of Visualized Experiments : Jove|August 23, 2014
Modeling astrocytoma pathogenesis in vitro and in vivo using cortical astrocytes or neural stem cells from conditional, genetically engineered miceRobert S McNeill, Ralf S Schmid, Ryan E Bash, et al.
Neuro-Oncology|July 2, 2013
Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesisMark Vitucci, Natalie O Karpinich, Ryan E Bash, et al.
Neuro-Oncology|January 31, 2016
Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomideRalf S Schmid, Jeremy M Simon, Mark Vitucci, et al.
Neuro-Oncology|April 12, 2017
Genomic profiles of low-grade murine gliomas evolve during progression to glioblastomaMark Vitucci, David M Irvin, Robert S McNeill, et al.
Nature Communications|March 15, 2018
Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodelingCarla Danussi, Promita Bose, Prasanna T Parthasarathy, et al.
Nature Communications|January 6, 2022
Author Correction: Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodelingCarla Danussi, Promita Bose, Prasanna T Parthasarathy, et al.
Pageof 2